newsfilter
← Latest News
GlobeNewswire·

GeoVax to Participate in Upcoming October Investor and Industry Events

Company to Provide Updates on Phase 2 Clinical Trialsfor Next Generation COVID-19 Vaccine and Cancer Immunotherapy Programs ATLANTA, GA, Sept. 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax